Clinical Trial Update: Palbociclib Combined With an Aromatase Inhibitor in Breast Cancer [Phase 3]

View source ↗

Summary

Phase 3 trial evaluating palbociclib in combination with an aromatase inhibitor for breast cancer is reported.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Breast Cancer

Drugs mentioned

• Palbociclib (palbociclib)

Snippet

Sponsor: Shengjing Hospital | Conditions: Breast Cancer | Phase 3 | Status: UNKNOWN